Literature DB >> 23266610

MicroRNA-501 promotes HBV replication by targeting HBXIP.

Jiang Jin1, Shanhong Tang, Lin Xia, Rui Du, Huahong Xie, Jiugang Song, Rui Fan, Qian Bi, Zheng Chen, Guitao Yang, Jie Liu, Yongquan Shi, Daiming Fan.   

Abstract

MicroRNAs (miRNAs) can negatively regulate gene expression and also induce or inhibit viral replication. In the present study, we found 10 miRNAs were differentially expressed in a stable HBV-producing cell line (HepG2.2.15) compared with its control cell line (HepG2) by miRNA array analysis. miR-501 was significantly up-regulated in HepG2 cells and tissues with high-HBV replication. miR-501 expression was significantly up-regulated in hepatocellular carcinoma tissues, where HBV replication kept high. Down-regulating miR-501 could significantly inhibit HBV replication, but not influence the growth of HepG2.2.15 cells. Luciferase reporter and western blot assays revealed that HBXIP, an inhibitor of HBV replication, was a potential target of miR-501. Moreover, knockdown of HBXIP rescued the inhibition of HBV that occurred after the loss of miR-501 in HepG2.2.15 cells, suggesting that miR-501 induced HBV replication partially by targeting HBXIP. Thus, knockdown of miR-501 might provide a new mechanism and therapeutic target for inhibiting HBV replication.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266610     DOI: 10.1016/j.bbrc.2012.12.071

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

2.  [Expression profile of miR-501-5p in lung adenocarcinoma patients from Xuanwei area].

Authors:  Shuai Chen; Yong-Chun Zhou; Ying Chen; Xiao-Bo Chen; Guang-Jian Li; Yu-Jie Lei; Lin-Wei Tian; Guang-Qiang Zhao; Qiubo Huang; Yunc-Hao Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

Review 3.  Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shan-Ying Wu; Sheng-Hui Lan; Hsiao-Sheng Liu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

5.  Hepatitis B X-interacting protein promotes the formation of the insulin gene-transcribing protein complex Pdx-1/Neurod1 in animal pancreatic β-cells.

Authors:  Hang Li; Zhen Wang; Yinghui Li; Runping Fang; Huawei Wang; Hui Shi; Xiaodong Zhang; Weiying Zhang; Lihong Ye
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

Review 6.  Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.

Authors:  Jason Lamontagne; Laura F Steel; Michael J Bouchard
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 7.  Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication.

Authors:  Yoshiaki Mizuguchi; Toshihiro Takizawa; Eiji Uchida
Journal:  World J Hepatol       Date:  2015-04-08

8.  Exosomal transfer of miR-429 confers chemoresistance in epithelial ovarian cancer.

Authors:  Taoqiong Li; Li Lin; Qin Liu; Wujiang Gao; Lu Chen; Chunli Sha; Qi Chen; Wenlin Xu; Yuefeng Li; Xiaolan Zhu
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 9.  Roles of hepatocyte nuclear factors in hepatitis B virus infection.

Authors:  Doo Hyun Kim; Hong Seok Kang; Kyun-Hwan Kim
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

Review 10.  MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects.

Authors:  Yi Lin Jane Tan; Wei Ning Chen
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.